Robert Gibbons

University of Chicago, United States

Adaptive Testing Technologies (Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• Use of Central Nervous System Drugs in Combination with Selective Serotonin Reuptake Treatment: A Bayesian Screening Study for Risk of Suicidal Behavior

  Sunday, August 28, 2022
  8:45 AM – 9:00 AM CEST